Viveve Medical, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2019. For the quarter, the company reported revenue of $3,012,000 compared to $3,699,000 a year ago. Loss from operations was $8,777,000 compared to $11,340,000 a year ago. Net loss was $10,029,000 or $0.22 per basic and diluted share compared to $12,669,000 or $0.49 per basic and diluted share a year ago.

The company continues to anticipate solid commercial growth and reiterates its 2019 guidance for annual revenue of $20 million.